Detection of mosaic and population-level structural variants with Sniffles2
- PMID: 38168980
- PMCID: PMC11217151
- DOI: 10.1038/s41587-023-02024-y
Detection of mosaic and population-level structural variants with Sniffles2
Erratum in
-
Publisher Correction: Detection of mosaic and population-level structural variants with Sniffles2.Nat Biotechnol. 2024 Oct;42(10):1616. doi: 10.1038/s41587-024-02141-2. Nat Biotechnol. 2024. PMID: 38253882 Free PMC article. No abstract available.
Abstract
Calling structural variations (SVs) is technically challenging, but using long reads remains the most accurate way to identify complex genomic alterations. Here we present Sniffles2, which improves over current methods by implementing a repeat aware clustering coupled with a fast consensus sequence and coverage-adaptive filtering. Sniffles2 is 11.8 times faster and 29% more accurate than state-of-the-art SV callers across different coverages (5-50×), sequencing technologies (ONT and HiFi) and SV types. Furthermore, Sniffles2 solves the problem of family-level to population-level SV calling to produce fully genotyped VCF files. Across 11 probands, we accurately identified causative SVs around MECP2, including highly complex alleles with three overlapping SVs. Sniffles2 also enables the detection of mosaic SVs in bulk long-read data. As a result, we identified multiple mosaic SVs in brain tissue from a patient with multiple system atrophy. The identified SV showed a remarkable diversity within the cingulate cortex, impacting both genes involved in neuron function and repetitive elements.
© 2024. The Author(s).
Conflict of interest statement
F.J.S. receives research support from PacBio, Genetech and Oxford Nanopore Technologies. S.W.S. is a member of the Scientific Advisory Council of the Lewy Body Dementia Association and the Multiple System Atrophy Coalition. S.W.S. is an editorial board member of JAMA Neurology and the Journal of Parkinson’s Disease. L.F.P. is sponsored by Genentech, Inc. K.H. is an employee of Bionano Genomics. D.P. provides consulting service for Ionis Pharmaceuticals. The remaining authors declare no competing interests.
Figures
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
